Fluorometholone Ophthalmic Drops or Ointment |
Eflone; Flarex; Fluor-Op; FML; FML Forte |
Clinical Trial: Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Vs. Placebo in Healthy Volunteers
This study has been completed.
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| healthy subjects | Drug: Povidone K25 eye drops (povidone) | Phase IV |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Local Tolerability and Safety of Povidone K25 (Artificial Tears Containing Povidone) Vs. Placebo in Healthy Volunteers
Study start: March 2004
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria:
- healthy subjects
- older than 18 years
- ocular discomfort less than 20 mm on 100 mm VAS prior to treatment
Exclusion Criteria:
- known hypersensitivity to any of the constituents of the medications
- known allergic disposition (e.g. hay fever)
- wearing of contact lenses
- any kind of current eye disease (e.g. dry eye) Additional exclusion criteria are defined in the protocol
Location Information
PD. Dr. G. Auffarth, Principal Investigator, Universitäts-Augenklinik, Im Neuenheimer Feld 400,
More Information
Last Updated: August 25, 2005
Record first received: August 25, 2005
ClinicalTrials.gov Identifier: NCT00135824
Health Authority: Germany: Federal Institute for Drugs and Medicinal Devices
ClinicalTrials.gov processed this record on 2005-08-30

Not Signed In -


